Fulcrum Therapeutics (FULC) Company Statistics | The Fly

Search...

/

Dashboard

Charting

KPIs

Stock Screener

ETF Screener

Earnings Calendar

Events Calendar

Syndicate

Street Research

Portfolios

Alert Settings

Fulcrum Therapeutics (FULC) Company Statistics | The Fly

© 2026 The Fly Inc.

The Fly Cast

Press play to listen

©

Fulcrum Therapeutics

· FULC

Dashboard

Financials

Ratios

Transcripts

Valuation

Statistics

282.3 M

+0.00%

General

Market Cap: $282.3M
Enterprise Value: $239.11M
Shares Outstanding: 66,630,000
Dividend: —
Employees: —
Revenue Per Employee: —

Fundamental Ratios (TTM)

Gross Margin: —
Operating Margin: —
Net Profit Margin: —
FCF Margin: —
ROA: -26.24%
ROE: -28.54%
ROIC: -27.40%
Current Ratio: 31.35
Debt-to-Equity: 0.02
Revenue Per Employee: —

Valuation (TTM)

P/E: —
PEG: —
P/S: —
P/FCF: —
P/B: 0.91
EV/EBITDA: -3.09

Growth

Rev 1Y: —
Rev 1Y Fwd Est: —
Rev 3Y (CAGR): —
Rev 5Y (CAGR): —
Rev 10Y (CAGR): —
EPS 1Y: —
EPS 1Y Fwd Est: —
EPS 3Y (CAGR): —
EPS 5Y (CAGR): —
EPS 10Y (CAGR): —

Income Statement (TTM)

Revenue: —
Gross Margin: —
Operating Expenses: $72.09M
Operating Income: -$86.64M
Net Profit: -$85M

Balance Sheet

Cash and Equivalents: $48.47M
Working Capital: $312.55M
Total Assets: $323.95M
Net Debt: -$43.19M
Total Liabilities: $13.26M
Total Equity: $310.7M

Cash Flow Statement (TTM)

Cash Flow from Operations: -$65.78M
Cash Flow from Investing: -$96.87M
Cash Flow from Financing: $168.41M
Free Cash Flow: -$66.14M
Capital Expenditures: $365K